Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 96,010 shares at $9.77 ($890K) on 2021-07-01, disclosed to the SEC on 2021-07-06.
Open-market sale of $890k PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.77 | 9,834 | $96K | 10.8% |
| 2 | $9.77 | 9,834 | $96K | 10.8% |
| 3 | $9.77 | 10,729 | $105K | 11.8% |
| 4 | $9.77 | 10,729 | $105K | 11.8% |
| 5 | $8.90 | 14,266 | $127K | 14.3% |
| 6 | $8.90 | 13,076 |
| $116K |
| 13.1% |
| 7 | $8.90 | 14,266 | $127K | 14.3% |
| 8 | $8.90 | 13,076 | $116K | 13.1% |
| 9 | $9.65 | 104 | $1K | 0.1% |
| 10 | $9.65 | 96 | $926 | 0.1% |
| Total | $9.27 avg | 96,010 | $890K | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |